Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study
- PMID: 20095037
- PMCID: PMC3816512
- DOI: 10.1002/ajh.21585
Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study
Abstract
Heritability is the proportion of observed variation in a trait among individuals in a population that is attributable to hereditary factors. The Hemochromatosis and Iron Overload Screening family study estimated heritability of serum iron measures. Probands were HFE C282Y homozygotes or non-C282Y homozygotes with elevated transferrin saturation (TS > 50%, men; TS > 45%, women) and serum ferritin concentration (SF > 300 microg/L, men; SF > 200 microg/L, women). Heritability (h(2)) was estimated by variance component analysis of TS, natural logarithm (ln) of SF, and unsaturated iron-binding capacity (UIBC). Participants (N = 942) were 77% Caucasians, 10% Asians, 8% Hispanics, and 5% other race/ethnicities. Average age (SD) was 49 (16) years; 57% were female. For HFE C282Y homozygote probands and their family members, excluding variation due to HFE C282Y and H63D genotype and measured demographic and environmental factors, the residual h(2) (SE) was 0.21 (0.07) for TS, 0.37 (0.08) for ln SF, and 0.34 (0.08) for UIBC (all P < 0.0004 for comparisons with zero). For the non-C282Y homozygote proband group, residual h(2) was significant with a value of 0.64 (0.26) for ln SF (P = 0.0096). In conclusion, serum iron measures have significant heritability components, after excluding known genetic and nongenetic sources of variation.
Similar articles
-
Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.Blood Cells Mol Dis. 2010 Apr 15;44(4):252-6. doi: 10.1016/j.bcmd.2010.01.007. Epub 2010 Feb 23. Blood Cells Mol Dis. 2010. PMID: 20178892 Free PMC article.
-
Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.Am J Hematol. 2007 Oct;82(10):898-905. doi: 10.1002/ajh.20937. Am J Hematol. 2007. PMID: 17597476
-
HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.Genet Test. 2007 Fall;11(3):269-75. doi: 10.1089/gte.2007.0003. Genet Test. 2007. PMID: 17949288
-
Hemochromatosis and iron-overload screening in a racially diverse population.N Engl J Med. 2005 Apr 28;352(17):1769-78. doi: 10.1056/NEJMoa041534. N Engl J Med. 2005. PMID: 15858186
-
Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study.Can J Gastroenterol. 2009 Nov;23(11):769-72. doi: 10.1155/2009/839308. Can J Gastroenterol. 2009. PMID: 19893773 Free PMC article. Review.
Cited by
-
An efficient machine learning-based approach for screening individuals at risk of hereditary haemochromatosis.Sci Rep. 2020 Nov 26;10(1):20613. doi: 10.1038/s41598-020-77367-6. Sci Rep. 2020. PMID: 33244054 Free PMC article.
-
Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.Hematology Am Soc Hematol Educ Program. 2009:195-206. doi: 10.1182/asheducation-2009.1.195. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008199 Free PMC article.
-
Oxidative and glycolytic skeletal muscles deploy protective mechanisms to avoid atrophy under pathophysiological iron overload.J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1250-1261. doi: 10.1002/jcsm.12897. Epub 2022 Feb 3. J Cachexia Sarcopenia Muscle. 2022. PMID: 35118832 Free PMC article.
-
Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations.PLoS One. 2012;7(6):e38339. doi: 10.1371/journal.pone.0038339. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22761678 Free PMC article.
-
IRon Overload screeNing tool (IRON): development of a tool to guide screening in primary care.Am J Hematol. 2011 Sep;86(9):733-7. doi: 10.1002/ajh.22082. Epub 2011 Jul 28. Am J Hematol. 2011. PMID: 21800355 Free PMC article.
References
-
- Edwards CQ, Griffen LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355–62. - PubMed
-
- Motulsky AG, Beutler E. Population screening in hereditary hemochromatosis. Annu Rev Public Health. 2000;21:65–79. - PubMed
-
- Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med. 1998;129:932–9. - PubMed
-
- Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-05188/HC/NHLBI NIH HHS/United States
- N01 HC005192/HC/NHLBI NIH HHS/United States
- N01-HC-05186/HC/NHLBI NIH HHS/United States
- N01 HC005186/HC/NHLBI NIH HHS/United States
- N01 HC005189/HC/NHLBI NIH HHS/United States
- N01 HC005191/HC/NHLBI NIH HHS/United States
- M01-RR00827-29/RR/NCRR NIH HHS/United States
- N01-HC-05191/HC/NHLBI NIH HHS/United States
- R01 HL083328-01A1/HL/NHLBI NIH HHS/United States
- N01-HC-05189/HC/NHLBI NIH HHS/United States
- P30 CA062203/CA/NCI NIH HHS/United States
- N01 HC005185/HC/NHLBI NIH HHS/United States
- M01 RR000827/RR/NCRR NIH HHS/United States
- R01 HL083328/HL/NHLBI NIH HHS/United States
- N01 HC005190/HC/NHLBI NIH HHS/United States
- N01-HC-05190/HC/NHLBI NIH HHS/United States
- M01-RR10284/RR/NCRR NIH HHS/United States
- N01 HB067189/HL/NHLBI NIH HHS/United States
- UH1-HL03679-05/HL/NHLBI NIH HHS/United States
- M01 RR010284/RR/NCRR NIH HHS/United States
- M01 RR000032/RR/NCRR NIH HHS/United States
- UH1 HL003679/HL/NHLBI NIH HHS/United States
- N01 HC005188/HC/NHLBI NIH HHS/United States
- M01-RR00032/RR/NCRR NIH HHS/United States
- N01-HC-05185/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical